STAT - Reporting from the frontiers of health and medicine

Politics

Biotech

Politics

Biotech Alkermes buys Rodin Therapeutics for up to $950 million, giving it possible avenue for growth
Politics In a rare political move, prominent biotech venture capitalists speak out against Pelosi’s drug pricing bill
First Opinion In the hospital supply chain, too many choices can be costly
Health Tech Stanford’s new hospital is brimming with futuristic tech. Will it help save money — or drive up costs?
Health A new treatment promises to make little people taller. Is it an insult to ‘dwarf pride’?

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Patient charity settles allegations it helped MS drug makers pay kickbacks
FDA is urged to probe a Louisiana program for ‘illegally’ testing an addiction treatment on inmates
Warren and Sanders: More scrutiny needed of commercial boards that decide whether to green-light clinical trials

Don't Miss

By STAT

Health

Special Report

Special Report

Heavyweights

Health

Biotech FDA approves Alnylam’s Givlaari, second-ever drug based on RNAi
Biotech First CRISPR treatment for blood diseases shows early benefits in two patients
First Opinion Hopewell House hospice has closed. You should care about that
First Opinion Letting academic medical centers make CAR-T drugs would save billions
Politics Mystery solved: The American Hospital Association and CVS Health formed a shadowy, anti-pharma group with deep GOP ties